| Literature DB >> 29848520 |
Rodrigo Athayde Nemésio1,2, Beatriz Costa1,2, Carlos Abrantes3,4, Júlio Soares Leite1,2.
Abstract
Myeloid sarcoma (MS) is a rare condition that most commonly occurs in the setting of acute myeloidleukaemia (AML) or other chronic myeloproliferative disorders. It presents as an abnormal growth that can develop anywhere in the human body, and its clinical manifestations are often non-specific.We present the case of a patient admitted to the emergency room with bowel obstruction. After careful clinical assessment, she underwent a right hemicolectomy. After a thorough examination of the surgical pathology specimen, including testing a wide array of immunohistochemical markers, the patient was timely diagnosed with MS, allowing for the implementation of the appropriate treatment to achieve complete remission. This is crucial, since non-leukaemic patients with untreated MS always progress to AML, and have a better prognosis if adequate therapy is implemented early. Our patient is now in the second postoperative year and shows no signs of relapse. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.Entities:
Keywords: gastrointestinal surgery; malignant and benign haematology; pathology; small intestine cancer; surgical oncology
Mesh:
Year: 2018 PMID: 29848520 PMCID: PMC5976126 DOI: 10.1136/bcr-2017-222718
Source DB: PubMed Journal: BMJ Case Rep ISSN: 1757-790X